Cancer Drug Avastin Fights Brain Tumors
TUESDAY, Feb. 20 (HealthDay News) -- The cancer drug Avastin (bevacizumab) appears able to slow the growth of the most common and deadly form of brain cancer -- gliomas -- and extend patient survival, according to a pilot study conducted at Duke University Medical Center in Durham, N.C.
InfoWorld - Barracuda Networks plans to focus on finding prior art to defend itself and the open-source ClamAV project against patent claims by rival antivirus vendor Trend Micro, which stressed Tuesday that it owns a tested and valid patent.